⌘K

Login Start Free

Home/Filings/4/0001235645-05-000005

4//SEC Filing

NPS PHARMACEUTICALS INC 4

Accession 0001235645-05-000005

CIK 0000890465operating

View on SEC.gov Company Profile

Filed

Jul 18, 8:00 PM ET

Accepted

Jul 19, 5:00 PM ET

Size

7.9 KB

Accession

0001235645-05-000005

Insider Transaction Report

Form 4

Period: 2005-07-15

NPS PHARMACEUTICALS INCNPSP

VP, Drug Discovery

Transactions

Award
Stock Option
2005-07-15+5,925→ 5,925 total
Exercise: $11.71From: 2006-07-15Exp: 2015-07-15→ Common Stock (5,925 underlying)
Award
Stock Option
2005-07-15+438→ 438 total(indirect: By Spouse)
Exercise: $11.71From: 2006-07-15Exp: 2015-07-15→ Common Stock (438 underlying)

Footnotes (1)

[F1]Stock option granted under the 1998 Stock Option Plan. The option becomes exercisable based on the following four-year vesting schedule: 28% on the first anniversary of the grant, and 2% each month thereafter.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0000890465

Filing Metadata

Form type: 4
Filed: Jul 18, 8:00 PM ET
Accepted: Jul 19, 5:00 PM ET
Size: 7.9 KB

View on SEC.gov